|
FANCA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.280770E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.413700E-02 |
| Normal-vs-Stage2 |
8.313000E-01 |
| Normal-vs-Stage3 |
1.969600E-01 |
| Normal-vs-Stage4 |
3.044800E-01 |
| Stage1-vs-Stage2 |
2.335600E-03 |
| Stage1-vs-Stage3 |
2.525800E-01 |
| Stage1-vs-Stage4 |
2.502800E-01 |
| Stage2-vs-Stage3 |
2.612200E-02 |
| Stage2-vs-Stage4 |
8.291500E-02 |
| Stage3-vs-Stage4 |
7.722200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.268400E-02 |
| Normal-vs-AfricanAmerican |
5.547000E-01 |
| Normal-vs-Asian |
1.627840E-01 |
| Caucasian-vs-AfricanAmerican |
2.381600E-01 |
| Caucasian-vs-Asian |
3.135200E-01 |
| AfricanAmerican-vs-Asian |
5.205400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.608000E-01 |
| Normal-vs-Female |
1.020650E-01 |
| Male-vs-Female |
2.606400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.403500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.985600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.192000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.915200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.644700E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.677900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.811000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.887200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.125600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.005600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.744600E-01 |
| Classical-VS-Follicular |
2.72869999995429E-06 |
| Classical-VS-Other |
9.192400E-01 |
| Classical-VS-Normal |
4.716000E-02 |
| Tall-VS-Follicular |
2.226600E-04 |
| Tall-VS-Other |
5.253800E-01 |
| Tall-VS-Normal |
1.804080E-02 |
| Follicular-VS-Other |
1.475830E-01 |
| Follicular-VS-Normal |
6.873200E-01 |
| Other-VS-Normal |
4.678000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.611200E-01 |
| Normal-vs-N1 |
1.154040E-01 |
| N0-vs-N1 |
3.659000E-01 |
|
|
